Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BILL Holdings, Inc.BILL · Entity 3940 | Director | December 05, 2024 | December 10, 2024 |
| Bilander Acquisition Corp.TWCB · Entity 125127 | Director · Chief Executive Officer | July 15, 2021 | July 15, 2021 |
| DoubleVerify Holdings, Inc.DV · Entity 4486 | Director | May 21, 2026 | May 22, 2026 |
| GoDaddy Inc.GDDY · Entity 2569 | Director · Chief Executive Officer | July 02, 2019 | July 06, 2019 |
| GoodRx Holdings, Inc.GDRX · Entity 4838 | Director | June 16, 2026 | June 18, 2026 |
| ROVER GROUP, INC.NEBCU · Entity 93736 | Director | December 08, 2020 | December 09, 2020 |
| Stratim Cloud Acquisition Corp.SCAQ · Entity 115385 | Director | March 11, 2021 | March 11, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BILL Holdings, Inc.
Report date December 05, 2024 · Filed December 10, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,714 |
Reported balance
After 2024-12-05 transaction · row 1
1 source rowRow 1 · 2024-12-05 · Exercise / conversion · Acquired 2,883 · Balance 14,714 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-12-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-12-05 · Exercise / conversion · Disposed 2,883 · Balance 0 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2: 100% of the RSUs vested on December 5, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,095 |
Reported balance
After 2024-12-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-12-05 · Grant · Acquired 2,095 · Balance 2,095 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3: The RSUs shall be 100% vested on the earlier of (a) the date of next annual stockholders meeting and (b) one year from the date of grant, subject to continued service on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2: 100% of the RSUs vested on December 5, 2024.
F3: The RSUs shall be 100% vested on the earlier of (a) the date of next annual stockholders meeting and (b) one year from the date of grant, subject to continued service on such vesting date.
Bilander Acquisition Corp.
Report date July 15, 2021 · Filed July 15, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B common stockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-07-15 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: As described in the issuer's registration statement on Form S-1 (File No. 333-253419) under the heading "Principal Stockholders", the Class B common stock will automatically convert into shares of Class A common stock in three tranches after the issuer's initial business combination on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights. Shares of Class B common stock that are issued and outstanding on the ten year anniversary of issuer's initial business combination will be automatically forfeited for no consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: As described in the issuer's registration statement on Form S-1 (File No. 333-253419) under the heading "Principal Stockholders", the Class B common stock will automatically convert into shares of Class A common stock in three tranches after the issuer's initial business combination on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights. Shares of Class B common stock that are issued and outstanding on the ten year anniversary of issuer's initial business combination will be automatically forfeited for no consideration.
DoubleVerify Holdings, Inc.
Report date May 21, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy LLC | 46,526 |
Reported balance
After 2026-05-21 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-05-21 · Exercise / conversion · Acquired 14,609 · Balance 46,526 F1: Each restricted stock unit was granted on May 21, 2025 and represents a right to receive one share of common stock on a one-to-one basis. The restricted stock units fully vested on May 21, 2026. F2: Represents shares and restricted stock units held by Hilltopper LLC, which is wholly-owned by Mr. Wagner. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | IndirectBy LLC | 0 |
Reported balance
After 2026-05-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-21 · Exercise / conversion · Disposed 14,609 · Balance 0 F3: Restricted stock units convert into common stock on a one-for-one basis. F1: Each restricted stock unit was granted on May 21, 2025 and represents a right to receive one share of common stock on a one-to-one basis. The restricted stock units fully vested on May 21, 2026. F2: Represents shares and restricted stock units held by Hilltopper LLC, which is wholly-owned by Mr. Wagner. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | IndirectBy LLC | 20,000 |
Reported balance
After 2026-05-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-21 · Grant · Acquired 20,000 · Balance 20,000 F3: Restricted stock units convert into common stock on a one-for-one basis. F4: Represents time-based restricted stock units granted on May 21, 2026 pursuant to the annual equity grant under DoubleVerify Holdings, Inc.'s non-employee director compensation program. The restricted stock units vest on the earlier of (i) May 21, 2027 and (ii) the date of DoubleVerify Holdings, Inc.'s 2027 Annual Meeting of Stockholders, subject to the reporting person's continued service. F2: Represents shares and restricted stock units held by Hilltopper LLC, which is wholly-owned by Mr. Wagner. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit was granted on May 21, 2025 and represents a right to receive one share of common stock on a one-to-one basis. The restricted stock units fully vested on May 21, 2026.
F2: Represents shares and restricted stock units held by Hilltopper LLC, which is wholly-owned by Mr. Wagner.
F3: Restricted stock units convert into common stock on a one-for-one basis.
F4: Represents time-based restricted stock units granted on May 21, 2026 pursuant to the annual equity grant under DoubleVerify Holdings, Inc.'s non-employee director compensation program. The restricted stock units vest on the earlier of (i) May 21, 2027 and (ii) the date of DoubleVerify Holdings, Inc.'s 2027 Annual Meeting of Stockholders, subject to the reporting person's continued service.
GoDaddy Inc.
Report date July 02, 2019 · Filed July 06, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common Stock, par value $0.001 per shareSEC Table I · non-derivative | Direct | 219,804 |
Reported balance
After 2019-07-02 transaction · row 1
1 source rowRow 1 · 2019-07-02 · Sale · Disposed 7,606 · Balance 219,804 F1: Represents shares of Class A Common Stock of the Issuer sold to satisfy the Reporting Person's tax withholding obligations. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Class A Common Stock of the Issuer sold to satisfy the Reporting Person's tax withholding obligations.
GoodRx Holdings, Inc.
Report date June 16, 2026 · Filed June 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 290,097 |
Reported balance
After 2026-06-16 transaction · row 1
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 73,434 · Balance 290,097 F1: Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) the one-year anniversary of June 16, 2026 and (ii) the date of the 2027 Annual Meeting of Stockholders, subject to Reporting Person's continued service through the applicable vesting date. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Wagner Family Trust | 182,900 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 182,900 F2: Shares held directly by the Wagner Family Trust (the "Trust"). The Reporting Person and his spouse serve as trustees of the Trust, and the Reporting Person, his spouse and other members of his immediate family are the sole beneficiaries of the Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) the one-year anniversary of June 16, 2026 and (ii) the date of the 2027 Annual Meeting of Stockholders, subject to Reporting Person's continued service through the applicable vesting date.
F2: Shares held directly by the Wagner Family Trust (the "Trust"). The Reporting Person and his spouse serve as trustees of the Trust, and the Reporting Person, his spouse and other members of his immediate family are the sole beneficiaries of the Trust.
ROVER GROUP, INC.
Report date December 08, 2020 · Filed December 09, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2020-12-08 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: The shares of Class B Common Stock are convertible for shares of the Issuer's Class A Common Stock as described under the heading "Description of Securities - Founder Shares" in the Issuer's registration statement on Form S-1 (File No. 333-250804) and have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of Class B Common Stock are convertible for shares of the Issuer's Class A Common Stock as described under the heading "Description of Securities - Founder Shares" in the Issuer's registration statement on Form S-1 (File No. 333-250804) and have no expiration date.
Stratim Cloud Acquisition Corp.
Report date March 11, 2021 · Filed March 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B common stockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-03-11 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: As described in the issuer's registration statement on Form S-1 (File No. 333-253174) under the heading "Description of Securities--Founder Shares," the shares of Class B common stock, par value $0.0001 per share, of the issuer will automatically convert into shares of Class A common stock, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustment, and have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: As described in the issuer's registration statement on Form S-1 (File No. 333-253174) under the heading "Description of Securities--Founder Shares," the shares of Class B common stock, par value $0.0001 per share, of the issuer will automatically convert into shares of Class A common stock, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustment, and have no expiration date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TWC Tech Holdings II Corp.
Report date August 30, 2021 · Filed September 01, 2021
Section 16 reporting ended · disclosed 2021-09-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2021-08-30 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-08-30 · Exercise / conversion · Acquired 25,000 · Balance 25,000 F1: On August 30, 2021, TWC Tech Holdings II Corp. (the "Issuer") consummated its business combination (the "Business Combination") with Cellebrite DI Ltd. ("Cellebrite"). Immediately prior to the effective time of the Business Combination, each share of Class B common stock of the Issuer automatically converted into a share of Class A common stock of the Issuer ("Class A Common Stock") on a one-for-one basis. Row 2 · 2021-08-30 · Disposition to issuer · Disposed 25,000 · Balance 0 F2: On August 30, 2021, in connection with the closing of the Business Combination, pursuant to a Business Combination Agreement and Plan of Merger (the "Business Combination Agreement"), Cupcake Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Cellebrite ("Merger Sub") merged with and into the Issuer and the Issuer continued as the surviving corporation in the merger and as a wholly owned subsidiary of Cellebrite (the "Merger"). In connection with the Merger, each share of Class A Common Stock was converted into the right to receive one ordinary share of Cellebrite, as set forth in the Business Combination Agreement. |
| Class B Common StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-08-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-08-30 · Exercise / conversion · Disposed 25,000 · Balance 0 F1: On August 30, 2021, TWC Tech Holdings II Corp. (the "Issuer") consummated its business combination (the "Business Combination") with Cellebrite DI Ltd. ("Cellebrite"). Immediately prior to the effective time of the Business Combination, each share of Class B common stock of the Issuer automatically converted into a share of Class A common stock of the Issuer ("Class A Common Stock") on a one-for-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 30, 2021, TWC Tech Holdings II Corp. (the "Issuer") consummated its business combination (the "Business Combination") with Cellebrite DI Ltd. ("Cellebrite"). Immediately prior to the effective time of the Business Combination, each share of Class B common stock of the Issuer automatically converted into a share of Class A common stock of the Issuer ("Class A Common Stock") on a one-for-one basis.
F2: On August 30, 2021, in connection with the closing of the Business Combination, pursuant to a Business Combination Agreement and Plan of Merger (the "Business Combination Agreement"), Cupcake Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Cellebrite ("Merger Sub") merged with and into the Issuer and the Issuer continued as the surviving corporation in the merger and as a wholly owned subsidiary of Cellebrite (the "Merger"). In connection with the Merger, each share of Class A Common Stock was converted into the right to receive one ordinary share of Cellebrite, as set forth in the Business Combination Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2026 Filed Jun 18, 2026 00:29 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 73,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000123 · wk-form4_1781742557.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,097 F1 · shares: Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) the one-year anniversary of June 16, 2026 and (ii) the date of the 2027 Annual Meeting of Stockholders, subject to Reporting Person's continued service through the applicable vesting date. Read SEC document |
| May 21, 2026 Filed May 22, 2026 20:25 UTC | DoubleVerify Holdings, Inc. DV · Entity 4486 | GrantRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001819928-26-000063 · form4.xml · derivative · entry 3 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: Represents time-based restricted stock units granted on May 21, 2026 pursuant to the annual equity grant under DoubleVerify Holdings, Inc.'s non-employee director compensation program. The restricted stock units vest on the earlier of (i) May 21, 2027 and (ii) the date of DoubleVerify Holdings, Inc.'s 2027 Annual Meeting of Stockholders, subject to the reporting person's continued service. F4 · derivative.expiration_date: Represents time-based restricted stock units granted on May 21, 2026 pursuant to the annual equity grant under DoubleVerify Holdings, Inc.'s non-employee director compensation program. The restricted stock units vest on the earlier of (i) May 21, 2027 and (ii) the date of DoubleVerify Holdings, Inc.'s 2027 Annual Meeting of Stockholders, subject to the reporting person's continued service. F2 · ownership.nature: Represents shares and restricted stock units held by Hilltopper LLC, which is wholly-owned by Mr. Wagner. Read SEC document |
| May 21, 2026 Filed May 22, 2026 20:25 UTC | DoubleVerify Holdings, Inc. DV · Entity 4486 | Exercise / conversionRestricted Stock Units · Derivative | 14,609 | $0.00 | $0.00 |
DisclosureSEC source: 0001819928-26-000063 · form4.xml · derivative · entry 2 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 0 Underlying: Common Stock · 14,609 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Each restricted stock unit was granted on May 21, 2025 and represents a right to receive one share of common stock on a one-to-one basis. The restricted stock units fully vested on May 21, 2026. F1 · derivative.expiration_date: Each restricted stock unit was granted on May 21, 2025 and represents a right to receive one share of common stock on a one-to-one basis. The restricted stock units fully vested on May 21, 2026. F2 · ownership.nature: Represents shares and restricted stock units held by Hilltopper LLC, which is wholly-owned by Mr. Wagner. Read SEC document |
| May 21, 2026 Filed May 22, 2026 20:25 UTC | DoubleVerify Holdings, Inc. DV · Entity 4486 | Exercise / conversionCommon Stock | 14,609 | $0.00 | $0.00 |
DisclosureSEC source: 0001819928-26-000063 · form4.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 46,526 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit was granted on May 21, 2025 and represents a right to receive one share of common stock on a one-to-one basis. The restricted stock units fully vested on May 21, 2026. F2 · ownership.nature: Represents shares and restricted stock units held by Hilltopper LLC, which is wholly-owned by Mr. Wagner. Read SEC document |
| January 21, 2026 Filed Jan 21, 2026 22:20 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionDeferred Stock Unit · Derivative | 31,394 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000008 · wk-form4_1769034033.xml · derivative · entry 2 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,788 Underlying: Class A Common Stock · 31,394 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F1 · derivative.exercise_date: The deferred stock unit award vested as to one-third of the shares underlying the award on January 21, 2026. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). F1 · derivative.expiration_date: The deferred stock unit award vested as to one-third of the shares underlying the award on January 21, 2026. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| January 21, 2026 Filed Jan 21, 2026 22:20 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 31,394 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-26-000008 · wk-form4_1769034033.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,663 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The deferred stock unit award vested as to one-third of the shares underlying the award on January 21, 2026. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). F2 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 00:57 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 3,065 | $0.00 | $0.00 |
DisclosureSEC source: 0001342655-25-000007 · wk-form4_1762217820.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,269 F1 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on November 30, 2025 and ending on December 31, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 22:48 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 57,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000089 · wk-form4_1749077314.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,204 F1 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units vest in full on the earlier of (i) the one-year anniversary of June 3, 2025 and (ii) the date of the 2026 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:02 UTC | DoubleVerify Holdings, Inc. DV · Entity 4486 | GrantRestricted Stock Units · Derivative | 14,609 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-077069 · ownership.xml · derivative · entry 3 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 14,609 Underlying: Common Stock · 14,609 shares Expires not disclosed F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: Represents time-based restricted stock units granted on May 21, 2025 pursuant to the annual equity grant under DoubleVerify Holdings, Inc.'s non-employee director compensation program. The restricted stock units vest on the earlier of (i) May 21, 2026 and (ii) the date of DoubleVerify Holdings, Inc.'s 2026 Annual Meeting of Stockholders, subject to Mr. Wagner's continued services. F4 · derivative.expiration_date: Represents time-based restricted stock units granted on May 21, 2025 pursuant to the annual equity grant under DoubleVerify Holdings, Inc.'s non-employee director compensation program. The restricted stock units vest on the earlier of (i) May 21, 2026 and (ii) the date of DoubleVerify Holdings, Inc.'s 2026 Annual Meeting of Stockholders, subject to Mr. Wagner's continued services. F2 · ownership.nature: Represents shares and restricted stock units held by Hilltopper LLC, which is wholly-owned by Mr. Wagner. Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:02 UTC | DoubleVerify Holdings, Inc. DV · Entity 4486 | Exercise / conversionRestricted Stock Units · Derivative | 10,724 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-077069 · ownership.xml · derivative · entry 2 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 0 Underlying: Common Stock · 10,724 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") was granted on May 23, 2024 and represents a right to receive one share of common stock on a one-to-one basis. The RSUs fully vested on May 21, 2025. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") was granted on May 23, 2024 and represents a right to receive one share of common stock on a one-to-one basis. The RSUs fully vested on May 21, 2025. F2 · ownership.nature: Represents shares and restricted stock units held by Hilltopper LLC, which is wholly-owned by Mr. Wagner. Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:02 UTC | DoubleVerify Holdings, Inc. DV · Entity 4486 | Exercise / conversionCommon Stock | 10,724 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-077069 · ownership.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 31,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") was granted on May 23, 2024 and represents a right to receive one share of common stock on a one-to-one basis. The RSUs fully vested on May 21, 2025. F2 · ownership.nature: Represents shares and restricted stock units held by Hilltopper LLC, which is wholly-owned by Mr. Wagner. Read SEC document |
| March 13, 2025 Filed Mar 14, 2025 21:39 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 64,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000051 · wk-form4_1741988364.xml · nonDerivative · entry 3 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,154 F3 · kind: Represents a gift of shares directly held by the Reporting Person to the Avery J. Wagner 2012 Irrevocable Trust for estate planning purposes. Following the transaction, the reporting person has neither investment control over nor a pecuniary interest in the transferred shares. Read SEC document |
| March 13, 2025 Filed Mar 14, 2025 21:39 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 64,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000051 · wk-form4_1741988364.xml · nonDerivative · entry 2 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,386 F2 · kind: Represents a gift of shares directly held by the Reporting Person to the Drew S. Wagner 2012 Irrevocable Trust for estate planning purposes. Following the transaction, the reporting person has neither investment control over nor a pecuniary interest in the transferred shares. Read SEC document |
| March 13, 2025 Filed Mar 14, 2025 21:39 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 64,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000051 · wk-form4_1741988364.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,618 F1 · kind: Represents a gift of shares directly held by the Reporting Person to the Charles W. Wagner 2012 Irrevocable Trust for estate planning purposes. Following the transaction, the reporting person has neither investment control over nor a pecuniary interest in the transferred shares. Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 22:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantDeferred Stock Unit · Derivative | 94,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000016 · wk-form4_1737670511.xml · derivative · entry 4 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,182 Underlying: Class A Common Stock · 94,182 shares Expires not disclosed F4 · derivative.exercise_price: Each deferred stock unit represents a contingent right to receive one share of Class A common stock. F5 · derivative.exercise_date: The deferred stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on January 21, 2026, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). F5 · derivative.expiration_date: The deferred stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on January 21, 2026, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 22:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 19,217 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000016 · wk-form4_1737670511.xml · nonDerivative · entry 2 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,850 F2 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units vest in full on the earlier of (i) June 6, 2025 and (ii) the date of the 2025 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 22:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 9,524 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000016 · wk-form4_1737670511.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 298,633 F1 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on January 31, 2025 and ending on December 31, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 23:43 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 70,591 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000210 · wk-form4_1733787775.xml · derivative · entry 4 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 70,591 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. F3 · derivative.expiration_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 23:43 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 35,776 | $4.91 | $175,660.16 |
DisclosureSEC source: 0001809519-24-000210 · wk-form4_1733787775.xml · nonDerivative · entry 2 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,109 Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 23:43 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 70,591 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000210 · wk-form4_1733787775.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 324,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 05, 2024 Filed Dec 10, 2024 00:13 UTC | BILL Holdings, Inc. BILL · Entity 3940 | GrantRestricted Stock Units · Derivative | 2,095 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-028729 · form4-12102024_121247.xml · derivative · entry 3 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,095 Underlying: Common Stock · 2,095 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: The RSUs shall be 100% vested on the earlier of (a) the date of next annual stockholders meeting and (b) one year from the date of grant, subject to continued service on such vesting date. F3 · derivative.expiration_date: The RSUs shall be 100% vested on the earlier of (a) the date of next annual stockholders meeting and (b) one year from the date of grant, subject to continued service on such vesting date. Read SEC document |
| December 05, 2024 Filed Dec 10, 2024 00:13 UTC | BILL Holdings, Inc. BILL · Entity 3940 | Exercise / conversionRestricted Stock Units · Derivative | 2,883 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-028729 · form4-12102024_121247.xml · derivative · entry 2 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,883 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: 100% of the RSUs vested on December 5, 2024. F2 · derivative.expiration_date: 100% of the RSUs vested on December 5, 2024. Read SEC document |
| December 05, 2024 Filed Dec 10, 2024 00:13 UTC | BILL Holdings, Inc. BILL · Entity 3940 | Exercise / conversionCommon Stock | 2,883 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-028729 · form4-12102024_121247.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 22:37 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 70,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000200 · wk-form4_1731451049.xml · derivative · entry 4 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,591 Underlying: Class A Common Stock · 70,592 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. F3 · derivative.expiration_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 22:37 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 35,777 | $5.04 | $180,316.08 |
DisclosureSEC source: 0001809519-24-000200 · wk-form4_1731451049.xml · nonDerivative · entry 2 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,294 Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 22:37 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 70,592 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000200 · wk-form4_1731451049.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| October 08, 2024 Filed Oct 8, 2024 21:06 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 70,591 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000181 · wk-form4_1728421611.xml · derivative · entry 4 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,183 Underlying: Class A Common Stock · 70,591 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. F3 · derivative.expiration_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. Read SEC document |
| October 08, 2024 Filed Oct 8, 2024 21:06 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 35,776 | $7.05 | $252,220.80 |
DisclosureSEC source: 0001809519-24-000181 · wk-form4_1728421611.xml · nonDerivative · entry 2 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,479 Read SEC document |
| October 08, 2024 Filed Oct 8, 2024 21:06 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 70,591 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000181 · wk-form4_1728421611.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 29, 2024 Filed Oct 1, 2024 21:19 UTC | BILL Holdings, Inc. BILL · Entity 3940 | Exercise / conversionRestricted Stock Units · Derivative | 449 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-024222 · form4-10012024_091019.xml · derivative · entry 2 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 449 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest on each of September 29, 2022, September 29, 2023, and September 29, 2024, subject to the continuing service of the Reporting Person on each vesting date. F2 · derivative.expiration_date: The RSUs vest on each of September 29, 2022, September 29, 2023, and September 29, 2024, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| September 29, 2024 Filed Oct 1, 2024 21:19 UTC | BILL Holdings, Inc. BILL · Entity 3940 | Exercise / conversionCommon Stock | 449 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-024222 · form4-10012024_091019.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,831 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| September 08, 2024 Filed Sep 9, 2024 23:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 70,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000175 · wk-form4_1725926311.xml · derivative · entry 4 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,774 Underlying: Class A Common Stock · 70,592 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. F3 · derivative.expiration_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. Read SEC document |
| September 08, 2024 Filed Sep 9, 2024 23:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 35,777 | $7.71 | $275,840.67 |
DisclosureSEC source: 0001809519-24-000175 · wk-form4_1725926311.xml · nonDerivative · entry 2 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,664 Read SEC document |
| September 08, 2024 Filed Sep 9, 2024 23:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 70,592 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000175 · wk-form4_1725926311.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,441 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| August 08, 2024 Filed Aug 8, 2024 21:16 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 70,591 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000168 · wk-form4_1723151764.xml · derivative · entry 4 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,366 Underlying: Class A Common Stock · 70,591 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. F3 · derivative.expiration_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. Read SEC document |
| August 08, 2024 Filed Aug 8, 2024 21:16 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 35,776 | $8.61 | $308,031.36 |
DisclosureSEC source: 0001809519-24-000168 · wk-form4_1723151764.xml · nonDerivative · entry 2 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,849 Read SEC document |
| August 08, 2024 Filed Aug 8, 2024 21:16 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 70,591 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000168 · wk-form4_1723151764.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| July 08, 2024 Filed Jul 8, 2024 21:36 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 70,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000128 · wk-form4_1720474580.xml · derivative · entry 4 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,957 Underlying: Class A Common Stock · 70,592 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. F3 · derivative.expiration_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. Read SEC document |
| July 08, 2024 Filed Jul 8, 2024 21:36 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 35,777 | $7.84 | $280,491.68 |
DisclosureSEC source: 0001809519-24-000128 · wk-form4_1720474580.xml · nonDerivative · entry 2 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,034 Read SEC document |
| July 08, 2024 Filed Jul 8, 2024 21:36 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 70,592 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000128 · wk-form4_1720474580.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 08, 2024 Filed Jun 10, 2024 23:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 70,591 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000110 · wk-form4_1718060712.xml · derivative · entry 4 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 423,549 Underlying: Class A Common Stock · 70,591 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. F3 · derivative.expiration_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. Read SEC document |
| June 08, 2024 Filed Jun 10, 2024 23:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 35,776 | $8.55 | $305,884.80 |
DisclosureSEC source: 0001809519-24-000110 · wk-form4_1718060712.xml · nonDerivative · entry 2 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,219 Read SEC document |
| June 08, 2024 Filed Jun 10, 2024 23:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 70,591 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000110 · wk-form4_1718060712.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| May 23, 2024 Filed May 28, 2024 20:13 UTC | DoubleVerify Holdings, Inc. DV · Entity 4486 | GrantRestricted Stock Units · Derivative | 10,724 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-065195 · ownership.xml · derivative · entry 3 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 10,724 Underlying: Common Stock · 10,724 shares Expires not disclosed F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: Represents time-based restricted stock units granted on May 23, 2024 pursuant to the annual equity grant under DoubleVerify Holdings, Inc.'s non-employee director compensation program. The restricted stock units vest on the earlier of (i) May 23, 2025 and (ii) the date of DoubleVerify Holdings, Inc.'s 2025 Annual Meeting of Stockholders, subject to Mr. Wagner's continued services. F4 · derivative.expiration_date: Represents time-based restricted stock units granted on May 23, 2024 pursuant to the annual equity grant under DoubleVerify Holdings, Inc.'s non-employee director compensation program. The restricted stock units vest on the earlier of (i) May 23, 2025 and (ii) the date of DoubleVerify Holdings, Inc.'s 2025 Annual Meeting of Stockholders, subject to Mr. Wagner's continued services. F2 · ownership.nature: Represents shares and restricted stock units held by Hilltopper LLC, which is wholly-owned by Mr. Wagner. Read SEC document |
| May 23, 2024 Filed May 28, 2024 20:13 UTC | DoubleVerify Holdings, Inc. DV · Entity 4486 | Exercise / conversionRestricted Stock Units · Derivative | 5,709 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-065195 · ownership.xml · derivative · entry 2 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 0 Underlying: Common Stock · 5,709 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") was granted on June 5, 2023 and represents a right to receive one share of common stock on a one-to-one basis. The RSUs fully vested on May 23, 2024. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") was granted on June 5, 2023 and represents a right to receive one share of common stock on a one-to-one basis. The RSUs fully vested on May 23, 2024. F2 · ownership.nature: Represents shares and restricted stock units held by Hilltopper LLC, which is wholly-owned by Mr. Wagner. Read SEC document |
| May 23, 2024 Filed May 28, 2024 20:13 UTC | DoubleVerify Holdings, Inc. DV · Entity 4486 | Exercise / conversionCommon Stock | 5,709 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-065195 · ownership.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 21,193 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") was granted on June 5, 2023 and represents a right to receive one share of common stock on a one-to-one basis. The RSUs fully vested on May 23, 2024. F2 · ownership.nature: Represents shares and restricted stock units held by Hilltopper LLC, which is wholly-owned by Mr. Wagner. Read SEC document |
| May 08, 2024 Filed May 8, 2024 21:50 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 70,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000077 · wk-form4_1715205001.xml · derivative · entry 4 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 494,140 Underlying: Class A Common Stock · 70,592 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. F3 · derivative.expiration_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. Read SEC document |
| May 08, 2024 Filed May 8, 2024 21:50 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 25,188 | $7.53 | $189,665.64 |
DisclosureSEC source: 0001809519-24-000077 · wk-form4_1715205001.xml · nonDerivative · entry 2 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,404 Read SEC document |
| May 08, 2024 Filed May 8, 2024 21:50 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 70,592 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000077 · wk-form4_1715205001.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 16, 2024 Filed Mar 19, 2024 22:28 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantStock Option (Right to Buy) · Derivative | 908,739 | $0.00 Strike: $6.91 | $0.00 |
DisclosureSEC source: 0001809519-24-000051 · wk-form4_1710887320.xml · derivative · entry 3 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 908,739 Underlying: Class A Common Stock · 908,739 shares Expires 2034-03-16 F4 · derivative.exercise_date: The option will vest and become exercisable in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.